<

INNATE PHARMA (EPA:IPH) Innate Pharma, a biopharmaceutical company developing first-in-class drugs targeting the innate immune system, updated on its next meetings with analysts and investors

Transparency directive : regulatory news

19/12/2007 17:44

source : webdisclosure.com

INNATE PHARMA's latest news


17/06/2024 07:00
23/05/2024 22:00
05/04/2024 09:34
19/03/2024 07:00
21/02/2024 07:00
03/11/2023 07:00
29/08/2023 07:00
10/08/2023 07:00
10/06/2023 07:00
12/05/2023 22:00


Other stories

31/10/2024 18:50
31/10/2024 21:53
31/10/2024 14:21
31/10/2024 18:11
31/10/2024 22:47
31/10/2024 20:35
31/10/2024 21:32
31/10/2024 21:37
31/10/2024 15:51
31/10/2024 22:59
31/10/2024 22:53
31/10/2024 19:54
31/10/2024 14:04
31/10/2024 10:30
01/11/2024 00:09
31/10/2024 18:49
31/10/2024 12:44
31/10/2024 13:18
31/10/2024 19:25
31/10/2024 18:50
31/10/2024 14:46
31/10/2024 15:00
31/10/2024 21:59
31/10/2024 22:38
31/10/2024 20:55
31/10/2024 22:00
01/11/2024 00:08
31/10/2024 18:02
31/10/2024 13:00
31/10/2024 20:07
31/10/2024 13:43
31/10/2024 12:15
30/10/2024 14:09
31/10/2024 19:52
31/10/2024 20:56
31/10/2024 11:44
30/10/2024 16:00
31/10/2024 08:16